Sensitization to MDMA locomotor effects and changes in the functionality of 5-HT2A and D2 receptors in mice

Behavioural Pharmacology

Volumn 22, Issue 4, 2011, Pages 362-369

  Varela, María José ^c   Brea, José ^c   Loza, Maria Isabel ^c   Maldonado, Rafael ^a   Robledo, Patricia ^a,b  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

context dependent; dopamine receptors; ecstasy; locomotor sensitization; serotonin receptors

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; DOPAMINE 2 RECEPTOR; SEROTONIN 2A RECEPTOR; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR MODIFICATION; BEHAVIOR THERAPY; CONTROLLED STUDY; LOCOMOTION; MALE; MOUSE; NONHUMAN;

ANIMALS; BEHAVIOR, ANIMAL; CORPUS STRIATUM; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HALLUCINOGENS; MALE; MICE; MOTOR ACTIVITY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PREFRONTAL CORTEX; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, DOPAMINE D2; SEROTONIN AGENTS;

EID: 79960696874     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0b013e3283487346     Document Type: Article

References (35)

1. Ball KT, Budreau D, Rebec GV (2003). Acute effects of 3,4-methylenedioxy-methamphetamine on striatal single-unit activity and behavior in freely moving rats: differential involvement of dopamine D1 and D2 receptors. Brain Res 994:203-215. (Pubitemid 37464884)
2. Ball KT, Budreau D, Rebec GV (2006). Context-dependent behavioural and neuronal sensitization in striatum to MDMA (ecstasy) administration in rats. Eur J Neurosci 24:217-228. (Pubitemid 44050681)
3. Ball KT, Wellman CL, Fortenberry E, Rebec GV (2009). Sensitizing regimens of ( ± )3,4-methylenedioxymethamphetamine (ecstasy) elicits enduring and differential structural alterations in the brain motive circuit of the rat. Neuroscience 160:264-274.
4. Biezonski DK, Courtemanche AB, Hong SB, Piper BJ, Meyer JS (2009). Repeated adolescent MDMA ('Ecstasy') exposure in rats increases behavioral and neuroendocrine responses to a 5-HT2A/2C agonist. Brain Res 1252:87-93.
5. Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
6. Brabant C, Tambour S, Tirelli E (2003). Quasi-asymptotic development of conditioned hyperactivity induced by intermittent injections of cocaine in C57BL/6J mice. Pharmacol Biochem Behav 75:273-280. (Pubitemid 36859811)
7. Colussi-Mas J, Schenk S (2008). Acute and sensitized response to 3,4-methylenedioxymethamphetamine in rats: different behavioral profiles reflected in different patterns of Fos expression. Eur J Neurosci 28: 1895-1910.
8. De Vries TJ, Schoffelmeer AN, Binnekade R, Mulder AH, Vanderschuren LJ (1998). Drug-induced reinstatement of heroin-and cocaine-seeking behaviour following long-term extinction is associated with expression of behavioural sensitization. Eur J Neurosci 10:3565-3571. (Pubitemid 29074147)
9. Dowling MR, Nahorski SR, Challiss RA (2004). Measurement of agonist-stimulated [35S]GTPgammaS binding to assess total G-protein and Galpha-subtype-specific activation by G-protein-coupled receptors. Methods Mol Biol 259:197-206.
10. Fornai F, Gesi M, Lenzi P, Ferrucci M, Lazzeri G, Pizzanelli C, et al. (2004) Effects of repeated low doses of MDMA on EEG activity and fluoro-jade B histochemistry. Ann N Y Acad Sci 1025:181-188. (Pubitemid 39643861)
11. Gerra G, Zaimovic A, Moi G, Giusti F, Gardini S, Delsignore R, et al. (2002) Effects of ( +/-) 3,4-methylene-dioxymethamphetamine (ecstasy) on dopa-mine system function in humans. Behav Brain Res 134:403-410. (Pubitemid 34912719)
12. González-Maeso J, Ang RL, Yuen T, Chan P, Weisstaub NV, López-Giménez JF, et al. (2008) Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature 452:93-97. (Pubitemid 351355090)
13. Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI (2003). The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphet-amine (MDMA, 'ecstasy'). Pharmacol Rev 55:463-508. (Pubitemid 37013213)
14. Han DD, Gu HH (2006). Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol 6:6.
15. Itzhak Y, Ali SF, Achat CN, Anderson KL (2003). Relevance of MDMA ('ecstasy')-induced neurotoxicity to long-lasting psychomotor stimulation in mice. Psychopharmacology (Berl) 166:241-248. (Pubitemid 36384770)
16. Kalivas PW, Duffy P, White SR (1998). MDMA elicits behavioral and neurochemical sensitization in rats. Neuropsychopharmacology 18:469-479. (Pubitemid 28202354)
17. Kehne JH, Ketteler HJ, McCloskey TC, Sullivan CK, Dudley MW, Schmidt CJ (1996). Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats. Neuropsychopharmacology 15:116-124. (Pubitemid 26255158)
18. McCreary AC, Bankson MG, Cunningham KA (1999). Pharmacological studies of the acute and chronic effects of ( + )-3,4-mehylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine1A and 5-hydroxytryptamine 1B/1D receptors. J Pharmacol Exp Ther 290:965-973. (Pubitemid 29400232)
19. Modi GM, Yang PB, Swann AC, Dafny N (2006). Chronic exposure to MDMA (Ecstasy) elicits behavioral sensitization in rats but fails to induce cross-sensitization to other psychostimulants. Behav Brain Funct 2:1-12.
20. Orejarena MJ, Lanfumey L, Maldonado R, Robedo P (2010). Involvement of 5-HT2A receptors in MDMA reinforcement and cue-induced reinstatement of MDMA seeking behaviour. Int J Neuropsychopharmacol 14:1-14.
21. Ramos M, Goñi-Allo B, Aguirre N (2004). Studies on the role of dopamine D1 receptors in the development and expression of MDMA-induced behavioural sensitization in rats. Psychopharmacology (Berl) 177:100-110. (Pubitemid 40109920)
22. Ramos M, Goñi-Allo B, Aguirre N (2005). Administration of SCH 23390 into the medial prefrontal cortex blocks the expression of MDMA-induced behavioural sensitization in rats: an effect mediated by 5-HT2C receptor stimulation and not by D1 receptor blockade. Neuropsychopharmacology 30:2180-2191. (Pubitemid 41643969)
23. Reneman L, Endert E, De Bruin K, Lavalaye J, Feenstra MG, De Wolff FA, et al. (2002) The acute and chronic effects of MDMA ('Ecstasy') on cortical 5-HT2A receptors in rat and human brain. Neuropsychopharmacology 26:387-396. (Pubitemid 34159216)
24. Robledo P (2010). Cannabinoids, opioids and MDMA: neuropsychological interactions related to addiction. Curr Drug Targets 11:429-439.
25. Salomon L, Lanteri C, Godeheu G, Blanc G, Gingrich J, Tassin JP (2007). Paradoxical constitutive behavioral sensitization to amphetamine in mice lacking 5-HT2A receptors. Psychopharmacology 194:11-20. (Pubitemid 47282731)
26. Scearce-Levie K, Viswanathan SS, Hen R (1999). Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT1B receptor. Psycho-pharmacology 141:154-161. (Pubitemid 29200166)
27. Scheffel U, Lever JR, Stathis M, Ricaurte GA (1992). Repeated administration of MDMA causes transient down-regulation of serotonin 5-HT2 receptors. Neuropharmacology 31:881-893.
28. Spanos LJ, Yamamoto BK (1989). Acute and subchronic effects of methylene-dioxymethamphetamine [( ± )MDMA] on locomotion and serotonin syndrome behavior in the rat. Pharmacol Biochem Behav 32:835-840. (Pubitemid 19210262)
29. Trigo JM, Renoir T, Lanfumey L, Hamon M, Lesch KP, Robledo P, et al. (2007). 3,4-Methylenedioxymethamphetamine self-administration is abolished in serotonin transporter knockout mice. Biol Psychiatry 62:669-679. (Pubitemid 47314373)
30. Vezina P, Leyton M (2009). Conditioned cues and the expression of stimulant sensitization in animals and humans. Neuropharmacology 56 (Suppl 1): 160168.
31. Volkow ND, Fowler JS, Wolf AP (1991). Use of positron emission tomography to study cocaine in the human brain. NIDA Res Monogr 112:168-179. (Pubitemid 23078453)
32. Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M, et al. (2001). Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 158:2015-2021. (Pubitemid 33104107)
33. Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Childress AR, et al. (2006). Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci 26:6583-6588. (Pubitemid 44318339)
34. Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F (2009). Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 56 (Suppl 1):38.
35. White SR, Obradovic T, Imel KM, Wheaton MJ (1996). The effects of methyl-enedioxymethamphetamine (MDMA,'ecstasy') on monoaminergic neurotrans-mission in the central nervous system. Prog Neurobiol 49:455-479. (Pubitemid 26312773)